It also has been shown to target BAK and p53 directly in Ewing sarcoma/primitive neuro‐ectodermal tumour,84 and it contributes to the increased proliferation and decreased apoptosis observed in chronic myeloid leukaemia, by repressing the activity of BAK1.85 Here, BAK1 is linked to Ewing sarcoma.